Testrol

Testrol, licence 80032843: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder: World Health Products LLC.
NPN or DIN-HM: 80032843
Status: Active licence
Licence date: 15 June 2012
Revision date: 31 March 2016
Form: Comprimé
Route of administration: Orale
Application type: Non traditionnelle

If this product were sold in France

Dose déclarée au-delà d'une limite
Zinc: up to 30 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
À vérifier
Zinc: up to 30 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSA for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Conditions légales
Turnera diffusa Willd. ex Schult.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
Mucuna pruriens Source : Graine(s) Extraction ratio : 6:1 Dry plant equivalent : 300 mg	50.0 mg	Not calculated
Zinc Source : Sulfate de zinc	15.0 mg	30,000 µg
Eurycoma Longifolia Source : Racine Extraction ratio : 50:1 Dry plant equivalent : 50 mg	1.0 mg	Not calculated
Serenoa repens Source : Fruit Extraction ratio : 4:1 Dry plant equivalent : 50 mg	12.5 mg	Not calculated
Turnera diffusa Source : Feuille	25.0 mg	Not calculated
L-arginine Source : Monohydrochlorure de L-arginine	75.0 mg	Not calculated
Ginkgo biloba Source : Feuille Extraction ratio : 50:1 Dry plant equivalent : 50 mg	1.0 mg	Not calculated
Sélénium Source : Sélénométhionine	25.0 mcg	50 µg
Trigonella foenum-graecum Source : Graine(s)	50.0 mg	Not calculated

Non-medicinal ingredients

Dioxyde de titanium, Stéarate de magnésium, propylèneglycol, Hypromellose, Croscarmellose de sodium, Laque d'aluminium-carmin d'indigo, Silice, Microcrystalline cellulose, Laque d'aluminium bleu FD&C n° 1, phosphate de dicalcium, Acide stéarique

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes de sexe masculin	Not specified	2.0 Comprimé	1.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps the body to metabolize carbohydrates, fats and proteins. Helps to maintain proper muscle function. An antioxidant for the maintenance of good health. Helps to maintain immune function. Helps in connective tissue formation. Helps in the development and maintenance of bones and teeth.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80032843

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 31 March 2016 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2016. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.